RightFit
RecruitingNot applicable

Evaluating Conversational Artificial Intelligence for Depression Management

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 85 Years
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests an AI chat tool that collects health history at home, compared with usual care. It looks at whether patients feel understood and cared for, and follows them for 4 months. It is for adults ages 18 to 85 with diagnosed or likely moderate to severe major depression.

The goal of this clinical trial is to evaluate how a conversational method of collecting medical history affects patients' perceptions and experiences compared to clinical care as usual. This conversational AI intake system collects medical history information, can be completed by participants at home, and do not disrupt routine clinical care. The primary questions this study aims to answer are: 1\) Does conversational intake affect patients' perceptions of empathy during their clinical interactions? This will be a prospective study that follows a cohort of participants for four (4) months after engaging with the AI intake system. Because each participant serves as his/her own control, both comparators will be administered within-subject, and the order of exposure (AI intake vs. usual care) will be randomized to minimize sequence effects. After completing the AI intake method, participants will rate their experience, particularly in terms of empathy and compare it to their usual interactions with their own clinicians.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Be 18 to 85 years old.
  • Have diagnosed or likely moderate to severe major depression.
  • Be able to communicate in English online.
  • Live in the United States.
  • Use a phone or computer located in the United States.
  • Have a mental health clinician, or be willing to see study clinicians to review the AI tool's advice and suggested medicine changes.
  • If seeing study clinicians, live in a state where they are licensed to provide care.

Who can't join

  • Have signs of bipolar depression, which involves depression and periods of unusually high mood or energy.
  • Be in an active suicide crisis or at immediate risk of suicide within the next 3 hours.
  • Be pregnant or trying to become pregnant.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

1. Participant is between 18 to 85 years old. 2. Participant has been, or are likely to be, diagnosed with moderate to severe Major Depressive Disorder without signs of bipolar depression. 3. Participant is not in active suicidal crisis and do not face imminent risk of suicide within the next 3 hours. 4. Participant is not pregnant or seeking to be pregnant. 5. Participant able to communicate in English on the Internet. 6. Participant must reside in the United States. 7. Participant has access to a mental health clinician, or the participant is willing to see study clinicians to help review the advice and medication adjustments recommended by the AI Intake System to the participant. 8. If the participant is seeing study clinicians, the participant must reside in a state where study clinicians are licensed. 9. Participant must be using a device (phone or computer) that is located in the United States.

Study sites (1)

VA